바로가기메뉴

본문 바로가기 주메뉴 바로가기

ACOMS+ 및 학술지 리포지터리 설명회

  • 한국과학기술정보연구원(KISTI) 서울분원 대회의실(별관 3층)
  • 2024년 07월 03일(수) 13:30
 

Azithromycin 투여로 폐기능이 호전된 폐쇄성 세기관지염 1예

Improvement of Pulmonary Function after Administration of Azithromycin in a Patient with Bronchiolitis Obliterans: a Case Report

Tuberculosis & Respiratory Diseases / Tuberculosis & Respiratory Diseases,
2008, v.65 no.5, pp.410-415
오지혜 (대구가톨릭대학교)
김성우 (대구가톨릭대학교)
현대성 (대구가톨릭대학교)
이상채 (대구가톨릭대학교)
배성화 (대구가톨릭대학교)
정경재 (대구가톨릭대학교)
권건영 (계명대학교)
김경찬 (대구가톨릭대학교 의과대학)
  • 다운로드 수
  • 조회수

초록

폐쇄성 세기관지염은 골수 이식 후 폐에 발생하는 합병증이다. 현재 스테로이드와 면역 억제제를 투여하여 적극적인 치료를 하더라도 폐기능의 호전을 보이는 경우는 일부에 불과하다. 저자들은 기존의 치료에도 불구하고 호전을 보이지 않은 골수 이식 후 발생한 폐쇄성 세기관지염 환자에서macrolide계 항생제인 azithromycin을 1년간 경구 투여하여 폐기능이 호전됨을 경험하였기에 문헌고찰과 함께 보고하는 바이다.

keywords
Bone marrow transplantation, Bronchiolitis obliterans, Pulmonary function, Azithromycin

Abstract

Bronchiolitis obliterans (BO) is a serious noninfectious complication following an allogeneic bone marrow transplant (BMT). A 21-year-old female received an allogeneic BMT as a treatment for myelodyplastic syndrome. Four months after the BMT, progressive dyspnea developed and BO was also diagnosed by a lung biopsy. The patient was administered steroid and immunosuppressive agents for 1 year but there was no improvement in pulmonary function. Azithromycin was prescribed (500 mg q.d. for 3 days followed by 250 mg three time a week) because macrolides might decrease the inflammatory reaction leading to BO. The patient’s pulmonary function improved after administration of azithromycin for 1 year. The forced expiratory volume in a one second (FEV1) increase was 220 mL (28.2%) and the forced vital capacity (FVC) increase was 460 mL (25.7%). We report the improvement in the pulmonary function after the administration of azithromycin for 1 year in a patient with BO after a BMT.

keywords
Bone marrow transplantation, Bronchiolitis obliterans, Pulmonary function, Azithromycin

참고문헌

1.

Roca J, (1982) Fatal airway disease in an adult with chronic graft-versus-host disease, Thorax

2.

Soubani AO, (2007) Bronchiolitis obliterans following haematopoietic stem cell transplantation, Eur Respir J

3.

Marras TK, (2003) Obliterative bronchiolitis complicating bone marrow transplantation, Semin Respir Crit Care Med

4.

Khalid M, (2005) Azithromycin in bronchiolitis obliterans complicating bone marrow transplantation: a preliminary study, Eur Respir J

5.

Katzenstein AL, (2006) Chap 16. Miscellaneous II. Nonspecific inflammatory and destructive diseases. In Surgical pathology of non-neoplastic lung disease, Saunders

6.

Kim CJ, (1998) Bronchiolitis obliterans and generalized vitiligo as rare presentations of chronic graft-versus-host disease, Korean J Pediatr Hematol-Oncol

7.

Afessa B, (2001) Bronchiolitis obliterans and other late onset non-infectious pulmonary complications in hematopoietic stem cell transplantation, Bone Marrow Transplant

8.

Corrin B, (2006) Chapter 3. Diseases of the airways. In Pathophysiology of the lungs, Churchill Livingstone

9.

Sakaida E, (2003) Late-onset noninfectious pulmonary complications after allogeneic stem cell transplantation are significantly associated with chronic graft-versus-host disease and with the graft-versus-leukemia effect, Blood

10.

Au WY, (2001) Respiratory ciliary function in bone marrow recipients, Bone Marrow Transplant

11.

Ringden O, (1999) Increased risk of chronic graft-versus- host disease, obstructive bronchiolitis, and alopecia with busulfan versus total body irradiation: long-term results of a randomized trial in allogeneic marrow recipients with leukemia, Blood

12.

Gerhardt SG, (2003) Maintenance azithromycin therapy for bronchiolitis obliterans syndrome: results of a pilot study, Am J Respir Crit Care Med

13.

Bashoura L, (2008) Inhaled corticosteroids stabilize constrictive bronchiolitis after hematopoietic stem cell transplantation, Bone Marrow Transplant

14.

Tamaoki J, (2004) The effects of macrolides on inflammatory cells, Chest

Tuberculosis & Respiratory Diseases